Biocybernetics

Meet Peter 2.0: One step closer to the Singularity

Phil Newman -
0
When Dr Peter Scott-Morgan was diagnosed with motor neurone disease, he decided to challenge what it means to be human. “Peter 2.0 is now online.”...
Read more
Investment

Longevity Week London: Key quotes and articles

Phil Newman -
0
Last week was a big turning point in Longevity: In key centres of academic and scientific endeavour the key players in Longevity aligned. The three intense...
Read more
Aging Analytics Agency profiles more than 50 biomarkers related to age-related diseases and syndromes.
Development

Longevity biomarkers mapped out in new report

Danny Sullivan -
0
Aging Analytics Agency profiles more than 50 biomarkers related to age-related diseases and syndromes. Earlier this...
SENS - Underdog Pharma
Development

SENS’ Underdog launches novel CVD treatment

Eleanor Garth -
0
SENS Research Foundation launches Underdog - a new therapeutic approach to cardiovascular disease (CVD). According to...
Dr Nir Barzilai at Longevity London 2019
Investment

Longevity Forum 2019 and the 150 year life

Phil Newman -
0
Leaders in the Longevity sector gather for annual Forum, with the message that people could...
First Longevity AI Consortium at King’s College London
AI

First Longevity AI Consortium launched at King’s

Salvinija Roznyte -
0
UK launch at King's College of AI Longevity Hub has bold plans for 2020 and...
Independent living

LifePod launches voice caregiving service

Danny Sullivan -
0
Company claims first voice-based service designed to improve quality of life for caregivers and care...
TISSUE/ORGAN | NANOTECH | SENESCENCE | CELLULAR | DRUGS | AI | NEURAL | AGETECH | INVESTMENT

FREE NEWSLETTER SIGN-UP | LONGEVITY MARKET | ABOUT US | LOGIN | YOUR ACCOUNT | SHARE YOUR NEWS | CONTACT US

PRIVACY POLICY | COOKIE POLICY | TERMS AND CONDITIONS | COPYRIGHT POLICY

© Copyright 2019 PERGALI Limited. All rights reserved. PERGALI, Longevity.Technology and their associated logos are trademarks of PERGALI Limited and are the subject of trademark applications or registrations in various countries around the world. All other trademarks are the property of their respective owners. All PERGALI products and services are subject to continuous development. We reserve the right to alter technical specifications without prior notice.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.